D
Biogen Inc. BIIB
$131.95 $3.953.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 10.00B 9.82B 9.68B 9.61B 9.67B
Total Other Revenue -- -- -- -- --
Total Revenue 10.00B 9.82B 9.68B 9.61B 9.67B
Cost of Revenue 2.35B 2.30B 2.22B 2.26B 2.28B
Gross Profit 7.64B 7.51B 7.45B 7.35B 7.39B
SG&A Expenses 2.41B 2.38B 2.38B 2.31B 2.49B
Depreciation & Amortization 460.50M 420.00M 386.50M 372.10M 302.70M
Other Operating Expenses 259.50M 246.90M 254.40M 251.60M 232.80M
Total Operating Expenses 7.36B 7.29B 7.19B 7.19B 7.50B
Operating Income 2.64B 2.53B 2.48B 2.41B 2.17B
Income Before Tax 1.80B 1.75B 1.91B 1.91B 1.31B
Income Tax Expenses 267.20M 273.10M 273.80M 291.70M 156.30M
Earnings from Continuing Operations 1.53K 1.48K 1.63K 1.61K 1.16K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- 800.00K 1.00M
Net Income 1.53B 1.48B 1.63B 1.62B 1.16B
EBIT 2.64B 2.53B 2.48B 2.41B 2.17B
EBITDA 3.38B 3.24B 3.15B 3.04B 2.75B
EPS Basic 10.48 10.15 11.21 11.11 7.97
Normalized Basic EPS 10.77 10.33 10.00 9.37 8.65
EPS Diluted 10.45 10.12 11.18 11.07 7.94
Normalized Diluted EPS 10.74 10.30 9.97 9.34 8.63
Average Basic Shares Outstanding 584.00M 583.10M 582.20M 581.40M 580.50M
Average Diluted Shares Outstanding 585.50M 584.70M 584.00M 583.60M 582.30M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --